The Latest in Diabetes Research and Treatment

The Latest in Diabetes Research and Treatment

Advances in Diabetes Treatment By Camille PeriWebMD Feature WebMD Feature Archive Diabetes treatment is getting better every day. Scientists may be just a few years away from making an artificial pancreas that can safely detect and adjust blood sugar (glucose) levels. In the meantime, new medications and insulin devices can make living with … Read more

Bumper profits for Norway’s giant wealth fund led by a strong performance by tech companies

Bumper profits for Norway’s giant wealth fund led by a strong performance by tech companies

STAVANGER — Norway’s oil fund reported the largest annual return in its history Tuesday, a performance led by U.S. technology companies and Danish pharmaceutical company Novo Nordisk, which makes the diabetes-turned-weight loss drug Ozempic. Norway’s Government Pension Fund Global, the world’s largest sovereign wealth fund, said it also benefited in 2023 from market excitement over … Read more

Insulin Just Got Cheaper Thanks To Joe Biden

Insulin Just Got Cheaper Thanks To Joe Biden

This article is part of HuffPost’s biweekly politics newsletter. Click here to subscribe. Lots of Americans say they are prepared to vote against President Joe Biden in November. Among the many reasons seems to be a persistent belief that Biden has accomplished “not very much” or “little or nothing” (according to an ABC-Washington Post poll … Read more

Homeless people who died on US streets are increasingly remembered at winter solstice gatherings

Homeless people who died on US streets are increasingly remembered at winter solstice gatherings

PHOENIX — With his gap-tooth smile, hip-hop routines and volunteer work for a food charity, Roosevelt White III was well known in the downtown Phoenix tent city known as “The Zone.” But like many homeless people, White suffered from diabetes and cardiovascular disease. He died unexpectedly one sweltering September day at age 36. Thousands of … Read more

Pfizer to discontinue twice-daily version of weight loss pill

Pfizer to discontinue twice-daily version of weight loss pill

Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost significant weight but had trouble tolerating the drug in a mid-stage clinical study.  The drugmaker observed high rates of adverse side effects, which were mostly mild and gastrointestinal, among patients. A … Read more